Precision BioSciences, Inc. Common Stock (DTIL) Stock Price, Quote & AI Analysis

Live DTIL stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Precision BioSciences, Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Precision BioSciences, Inc. Common Stock (DTIL), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

DTIL
Precision BioSciences, Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
3.920000
High
4.010000
Low
3.850000
Volume
48,261
VWAP
-
Market Cap
$95,324,133.96
52W Range
$3.75 - $8.82
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Mar 24, 2026 Q4
After Hours
EPS Estimate: $-0.5457
Revenue Estimate: $9,256,500.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Precision BioSciences, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Precision BioSciences, Inc. Common Stock Overview

Company information

Company Overview

Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and of novel products outside immuno-oncology to treat human diseases. The Food segment applies ARCUS, the company's proprietary genome editing platform, to develop food and nutrition products through collaboration agreements with consumer-facing companies. The company was founded by Derek N. Jantz, Jeff Smith, and Matthew R. Kane on January 26, 2006 and is headquartered in Durham, NC.

Company Details
Market Cap
$96.29M
Shares Outstanding
24,071,800
Weighted Shares Outstanding
24,071,751
CEO
Michael Amoroso
Address
302 EAST PETTIGREW STREET, DURHAM, NC, 27701
Employees
67
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Precision BioSciences, Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...